Sunday, February 08, 2015 6:55:02 PM
Plaintiffs in the Class Action: James T. Fahey (Highest Financial Stake)
The plaintiffs are:
(1) James T. Fahey
(2) Marshall Lee
(3) Jason Ebach and Mary Legnetti (“Ebach & Legnetti”)
(4) Allan L. Tereshko, Edward Buzz Bradley, and Edward Arduino (“Tereshko Investors Group”).
Tereskho Investors Group has also concluded that it does not have the largest financial stake in the outcome of the litigation, but has stated that the group remains willing to serve as lead plaintiff if the presumptive plaintiff is found to be an inadequate representative. Lucas, the Lewis Movants, and the Tereshko Investors Group have identified Fahey as the movant with the highest financial stake in the litigation.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=92348539
Interesting Read about the Class Action Law suit:
Fahey asserts that he purchased 439,000 shares of common stock in Peregrine securities during the class period by expending $1,074,933.46 in net expenditures.
Fahey additionally asserts that he purchased 8,645 option contracts for Peregrine securities and expended $775,360 for purchase of those options.
Finally, Fahey asserts that he suffered a loss of $375,269.78 as a result of Peregrine’s misrepresentations.
http://investorshub.advfn.com/boards/replies.aspx?msg=92348575
Great, he's a judge:
pview.findlaw.com/view/1788064_1
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=92348575
----------------------------------------------------------
If this is the same Allan L. Tereshko and one in the same judge, soon after Sept 2012 he was removed
http://www.thelegalintelligencer.com/id=1202576329138/Tereshko-Resigns-as-Supervising-Judge-in-Wake-of-Critical-Superior-Court-Decision?slreturn=20150108184841
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
